Calamos Advisors
EXEL icon

Calamos Advisors’s Exelixis EXEL Stock Holding History

Calamos Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,280
Closed -$542K – 931
2024
Q4 		$542K Buy
+16,280
New +$528K ﹤0.01% 722
2024
Q1 		– Sell
-67,884
Closed -$1.63M – 972
2023
Q4 		$1.63M Buy
+67,884
New +$1.48M 0.01% 621
2019
Q3 		– Sell
-31,350
Closed -$670K – 761
2019
Q2 		$670K Hold
31,350
– – ﹤0.01% 681
2019
Q1 		$746K Buy
+31,350
New +$715K ﹤0.01% 563

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Calamos Advisors's EXEL Position: Q1 2025 in Review

Calamos Advisors sold out of Exelixis (EXEL) in Q1 2025, closing a stake of 16,280 shares — an estimated $542K sold.

Calamos Advisors first reported a position in EXEL in Q1 2019 and held it in 4 quarters. The position peaked at $1.63M in Q4 2023. 557 funds tracked by Wall St. Rank hold EXEL as of Q1 2025.

  • Calamos Advisors reported no remaining Exelixis position as of Q1 2025 after selling out during the quarter.
  • Calamos Advisors sold 16,280 Exelixis shares in Q1 2025, an estimated $542K.
  • Calamos Advisors first reported a position in Exelixis in Q1 2019 and held it in 4 quarters.
  • Calamos Advisors's Exelixis position peaked at $1.63M in Q4 2023.
  • 557 funds tracked by Wall St. Rank held Exelixis as of Q1 2025.

Based on Calamos Advisors's 13F filing for Q1 2025, filed 29 Apr 2025.